Warning: The NCBI web site requires JavaScript to function. more...
Promoter methylation regulates cyclooxygenase expression in breast cancer.
Ma X, Yang Q, Wilson KT, Kundu N, Meltzer SJ, Fulton AM.
Breast Cancer Res. 2004;6(4):R316-21. Epub 2004 Apr 26.
Related citations
Promoter methylation regulates Helicobacter pylori-stimulated cyclooxygenase-2 expression in gastric epithelial cells.
Akhtar M, Cheng Y, Magno RM, Ashktorab H, Smoot DT, Meltzer SJ, Wilson KT.
Cancer Res. 2001 Mar 15;61(6):2399-403.
Aberrant methylation of the Cyclooxygenase 2 CpG island in colorectal tumors.
Toyota M, Shen L, Ohe-Toyota M, Hamilton SR, Sinicrope FA, Issa JP.
Cancer Res. 2000 Aug 1;60(15):4044-8.
Aberrant methylation of the specific CpG island portion regulates cyclooxygenase-2 gene expression in human gastric carcinomas.
Hur K, Song SH, Lee HS, Ho Kim W, Bang YJ, Yang HK.
Biochem Biophys Res Commun. 2003 Oct 24;310(3):844-51.
Increased cyclooxygenase-2 (cox-2) expression and activity in a murine model of metastatic breast cancer.
Kundu N, Yang Q, Dorsey R, Fulton AM.
Int J Cancer. 2001 Sep 1;93(5):681-6.
Transcriptional silencing of Cyclooxygenase-2 by hyper-methylation of the 5' CpG island in human gastric carcinoma cells.
Song SH, Jong HS, Choi HH, Inoue H, Tanabe T, Kim NK, Bang YJ.
Cancer Res. 2001 Jun 1;61(11):4628-35. Erratum in: Cancer Res 2001 Aug 1;61(15):5956.
Promoter hypermethylation of cyclooxygenase-2 in gastric carcinoma.
Yu J, Leung WK, Lee TL, Tse PC, To KF, Sung JJ.
Int J Oncol. 2003 May;22(5):1025-31.
Promoter hypermethylation silences cyclooxygenase-2 (Cox-2) and regulates growth of human hepatocellular carcinoma cells.
Murata H, Tsuji S, Tsujii M, Sakaguchi Y, Fu HY, Kawano S, Hori M.
Lab Invest. 2004 Aug;84(8):1050-9.
Aberrant promoter methylation and silencing of laminin-5-encoding genes in breast carcinoma.
Sathyanarayana UG, Padar A, Huang CX, Suzuki M, Shigematsu H, Bekele BN, Gazdar AF.
Clin Cancer Res. 2003 Dec 15;9(17):6389-94.
Wnt signalling in human breast cancer: expression of the putative Wnt inhibitor Dickkopf-3 (DKK3) is frequently suppressed by promoter hypermethylation in mammary tumours.
Veeck J, Bektas N, Hartmann A, Kristiansen G, Heindrichs U, Knüchel R, Dahl E.
Breast Cancer Res. 2008;10(5):R82. Epub 2008 Sep 30.
Methylation-associated silencing of death-associated protein kinase gene in laryngeal squamous cell cancer.
Kong WJ, Zhang S, Guo C, Zhang S, Wang Y, Zhang D.
Laryngoscope. 2005 Aug;115(8):1395-401.
DNA methylation-dependent silencing of CST6 in human breast cancer cell lines.
Rivenbark AG, Jones WD, Coleman WB.
Lab Invest. 2006 Dec;86(12):1233-42. Epub 2006 Oct 16.
Aberrant methylation and histone deacetylation of cyclooxygenase 2 in gastric cancer.
Kikuchi T, Itoh F, Toyota M, Suzuki H, Yamamoto H, Fujita M, Hosokawa M, Imai K.
Int J Cancer. 2002 Jan 20;97(3):272-7.
A cox-2 promoter-based replication-selective adenoviral vector to target the cox-2-expressing human bladder cancer cells.
Shirakawa T, Hamada K, Zhang Z, Okada H, Tagawa M, Kamidono S, Kawabata M, Gotoh A.
Clin Cancer Res. 2004 Jul 1;10(13):4342-8.
DNA methylation paradigm shift: 15-lipoxygenase-1 upregulation in prostatic intraepithelial neoplasia and prostate cancer by atypical promoter hypermethylation.
Kelavkar UP, Harya NS, Hutzley J, Bacich DJ, Monzon FA, Chandran U, Dhir R, O'Keefe DS.
Prostaglandins Other Lipid Mediat. 2007 Jan;82(1-4):185-97. Epub 2006 Jul 11.
Expression of estrogen receptor beta isoforms in normal breast epithelial cells and breast cancer: regulation by methylation.
Zhao C, Lam EW, Sunters A, Enmark E, De Bella MT, Coombes RC, Gustafsson JA, Dahlman-Wright K.
Oncogene. 2003 Oct 23;22(48):7600-6.
Effects of p53 or p27 overexpression on cyclooxygenase-2 gene expression in head and neck squamous cell carcinoma cell lines.
Lee DW, Park SW, Park SY, Heo DS, Kim KH, Sung MW.
Head Neck. 2004 Aug;26(8):706-15.
Promoter hypermethylation of the SFRP2 gene is a high-frequent alteration and tumor-specific epigenetic marker in human breast cancer.
Veeck J, Noetzel E, Bektas N, Jost E, Hartmann A, Knüchel R, Dahl E.
Mol Cancer. 2008 Nov 6;7:83.
Aberrant methylation of cyclooxygenase-2 in breast cancer patients.
Chow LW, Zhu L, Loo WT, Lui EL.
Biomed Pharmacother. 2005 Oct;59 Suppl 2:S264-7.
Signaling pathways regulating aromatase and cyclooxygenases in normal and malignant breast cells.
Richards JA, Petrel TA, Brueggemeier RW.
J Steroid Biochem Mol Biol. 2002 Feb;80(2):203-12. Review.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on